Combined radiotherapy and immune checkpoint inhibition for the treatment of advanced hepatocellular carcinoma

Hepatocellular Carcinoma (HCC) is one of the most common cancers and a leading cause of cancer related death worldwide. Until recently, systemic therapy for advanced HCC, defined as Barcelona Clinic Liver Cancer (BCLC) stage B or C, was limited and ineffective in terms of long-term survival. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Shannon, Alexander H., Manne, Ashish, Diaz Pardo, Dayssy A., Pawlik, Timothy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405730/
https://www.ncbi.nlm.nih.gov/pubmed/37554167
http://dx.doi.org/10.3389/fonc.2023.1193762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405730/
https://www.ncbi.nlm.nih.gov/pubmed/37554167
http://dx.doi.org/10.3389/fonc.2023.1193762

Ejemplares similares